I thought it was clear it was completed too. So why would the information about continuing the trial and filing additional paperwork with the FDA be in the 10Q? I think the data is kick ass and they want more of it for the other cancer types right now, rather than just ovarian data 6 months down the road. I almost wonder if CTIX might be considering filing the documents to progress the phase 1 trial into a phase 1B or even a phase 1/2 trial. That would be even sweeter!